Delivery Order SPE2DB20D3101-SPE2DB25FRML5
Award Date
6/9/25
Potential Completion Date
6/10/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,403,935 tablets of the drug Letrozole 2.5 mg. The $14,750.91 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of November 13, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,553.66 firm-fixed-price delivery order contract is for the provision of Letrozole 2.5 mg tablets. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to supply a wide range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,709,355 units of the drug Letrozole 2.5 mg tablet in 90-count packages. The contract has a ceiling value of $2,163.36 and an ultimate completion date of December 13, 2024. It is a delivery order contract with a firm fixed price. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $1,361.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,076,281 units of the medication Letrozole 2.5 mg tablet, with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside and is a firm fixed-price agreement. Amerisourcebergen Drug Corp, headquartered in...
This federal contract award, valued at $2,503.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 90-count packages of the prescription medication Letrozole 2.5 mg tablets, with a completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Letrozole 2.5 mg tablets to the Defense Logistics Agency (DLA). The $9,097.28 firm fixed-price delivery order has a completion date of February 27, 2025. The contract is not designated as a set-aside and is issued under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,881.70 firm-fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets. The contract has a period of performance ending on May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,966.87, is for the supply of Letrozole 2.5 mg tablets to support federal healthcare programs. The contract is a firm-fixed-price arrangement with a completion date of December 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,336.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of certain medical conditions. The contract is a delivery order with a firm fixed price, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,369.65 firm-fixed-price delivery order is for the purchase of 90-count tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...